Literature DB >> 17692712

Facial skeletal surgery in the management of adult obstructive sleep apnea syndrome.

Jose E Barrera1, Nelson B Powell, Robert W Riley.   

Abstract

Obstructive sleep apnea (OSA) remains a significant public health problem because of its neurocognitive sequelae. Additionally, with persistent obstruction, it has an impact on the cardiovascular system, leading to hypertension and cardiac failure as one of its causative or comorbid factors. For the surgeon managing OSA, there is a stepwise sequence of surgical procedures, from improving nasal airflow to facial skeletal maxillary-mandibular advancement, with the cumulative goal of volumetrically increasing the retropharyngeal airway space. Familiarity with conventional orthognathic principles is essential in achieving this goal.

Entities:  

Mesh:

Year:  2007        PMID: 17692712     DOI: 10.1016/j.cps.2007.04.010

Source DB:  PubMed          Journal:  Clin Plast Surg        ISSN: 0094-1298            Impact factor:   2.017


  3 in total

1.  Volumetric analysis of the pharynx in patients with obstructive sleep apnea (OSA) treated with maxillomandibular advancement (MMA).

Authors:  Ana Célia Faria; Savio Nogueira da Silva-Junior; Luis Vicente Garcia; Antonio Carlos dos Santos; Maria Regina França Fernandes; Francisco Veríssimo de Mello-Filho
Journal:  Sleep Breath       Date:  2012-05-06       Impact factor: 2.816

2.  Dynamic comparison of pharyngeal stability during sleep in patients with obstructive sleep apnea syndrome treated with maxillomandibular advancement.

Authors:  Ana Celia Faria; Luis Vicente Garcia; Antonio Carlos Santos; Alan Luiz Eckeli; Denny Marcos Garcia; Francisco Verissimo Mello-Filho
Journal:  Sleep Breath       Date:  2016-05-26       Impact factor: 2.816

3.  A preoperative predictive study of advantages of airway changes after maxillomandibular advancement surgery using computational fluid dynamics analysis.

Authors:  Kanako Yamagata; Keiji Shinozuka; Shouhei Ogisawa; Akio Himejima; Hiroaki Azaki; Shuichi Nishikubo; Takako Sato; Masaaki Suzuki; Tadashi Tanuma; Morio Tonogi
Journal:  PLoS One       Date:  2021-08-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.